Thrombosis in Cancer: An Update on Prevention, Treatment, and Survival Benefits of Anticoagulants (Q37829206)

24 August 2017

1 reference

title

Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants (English)

1 reference

24 August 2017

Thrombosis in Cancer: An Update on Prevention, Treatment, and Survival Benefits of Anticoagulants (English)

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

22 November 2024

0 references

1 reference

1 reference

Agnes Y. Y. Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21239784

22 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21239784

22 November 2024

publication date

1 January 2010

1 reference

24 August 2017

2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21239784

full work available at URL

22 November 2024

https://ashpublications.org/hematology/article-pdf/2010/1/144/1492268/bep00110000144.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21239784

http://www.asheducationbook.org/cgi/content/abstract/2010/1/144

22 November 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21239784

http://ashpublications.org/hematology/article-pdf/2010/1/144/1492268/bep00110000144.pdf

22 November 2024

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Hematology / the Education Program of the American Society of Hematology

22 November 2024

published in

1 reference

24 August 2017

volume

2010

1 reference

24 August 2017

page(s)

144-149

1 reference

Assessing risk of venous thromboembolism in the patient with cancer.

24 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Development and validation of a predictive model for chemotherapy-associated thrombosis

22 November 2024

2

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

22 November 2024

4

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy

22 November 2024

5

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.

22 November 2024

6

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

22 November 2024

7

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

22 November 2024

8

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial

22 November 2024

11

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients

22 November 2024

12

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

22 November 2024

13

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study

22 November 2024

14

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

22 November 2024

15

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project

22 November 2024

16

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study

22 November 2024

17

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

22 November 2024

18

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Venous thrombosis in cancer patients: insights from the FRONTLINE survey

22 November 2024

19

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

22 November 2024

22

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

22 November 2024

25

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

22 November 2024

26

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

22 November 2024

27

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Once-Daily Oral Rivaroxaban Versus Placebo in the Long-Term Prevention of Recurrent Symptomatic Venous Thromboembolism. the Einstein-Extension Study

22 November 2024

28

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry

22 November 2024

29

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.

22 November 2024

31

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Outcomes and cost of deep venous thrombosis among patients with cancer

22 November 2024

32

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study

22 November 2024

33

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.

22 November 2024

34

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation

22 November 2024

35

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis

22 November 2024

36

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

rNAPc2 inhibits colorectal cancer in mice through tissue factor

22 November 2024

37

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity

22 November 2024

38

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

Tissue factor, thrombin, and cancer

22 November 2024

39

1 reference

https://api.crossref.org/works/10.1182/ASHEDUCATION-2010.1.144

22 November 2024

Identifiers

1 reference

24 August 2017

1 reference